2m 2m 2m 2m 2m 2m 2m
KINIKSA PHARMA (KNSA)
NASDAQ
$75.70+$0.47 (+0.63%)
Price as of Oct 02, 2026 4:20 PM EDT- $3.2BMarket Cap
- 100.75%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
KINIKSA PHARMA (KNSA)
$75.70+$0.47 (+0.63%)
KNSA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $75.22 | ||
Change | +$0.61 (+0.82%) | ||
Open | $73.87 | ||
High | $76.11 | ||
Low | $73.14 | ||
Previous Close | $74.61 | ||
Volume | 878,562 | ||
30-Day Average Volume | 595,510 | ||
1-Week Change | -0.16% | ||
1-Month Change | -5.12% | ||
1-Year Change | 100.75% | ||
3-Year Change | 333.05% | ||
5-Year Change | 555.23% | ||
Fundamentals | |||
Shares Outstanding | 42.0M | ||
Total Assets | $896.1M | ||
Market Cap | $3.2B | ||
Enterprise Value | $3.0B | ||
Period: QTR TTM FY | |||
Revenue | $243.6M | ||
Net Income | $25.4M | ||
Free Cash Flow | $46.5M | ||
EBIT | $31.1M | ||
EBITDA | $31.6M | ||
Net Working Capital | $497.4M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | 94 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 5 | ||
P/E | 251 | ||
PEG | 23 | ||
Price/Free Cash Flow | 68 | ||
Price/Operating Cash Flow | 67 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue